• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其人群中甲状腺乳头状癌患者的白细胞介素-10基因多态性

Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.

作者信息

Erdogan M, Karadeniz M, Ozbek M, Ozgen A G, Berdeli A

机构信息

Department of Endocrinology and Metabolism Disease, Ege University Medical School, Bornova, Izmir, Turkey.

出版信息

J Endocrinol Invest. 2008 Sep;31(9):750-4. doi: 10.1007/BF03349252.

DOI:10.1007/BF03349252
PMID:18997484
Abstract

OBJECTIVE

Interleukin-10 (IL-10) is a major anti-inflammatory cytokine that plays a crucial role in the regulation of the immune system. Chronic inflammation has been reported to be a risk factor for thyroid neoplasia. The propensity to mount an inflammatory response is modified by germ line variation in cytokine and other inflammation-related genes. We hypothesized that a proinflammatory genotype would be positively associated with thyroid cancer. We aimed to evaluate the relation between the genotypic and allelic frequencies of the IL-10(-1082 G/A), IL-10(-592 A/C), and IL-10(-819 C/T) polymorphisms, and their association with the risk of developing papillary thyroid cancer (PTC) in the Turkish population.

RESEARCH DESIGN AND METHODS

Forty-two patients with PTC and 113 healthy controls were included in this study. The diagnosis of PTC was confirmed by histopathologic examination after surgery. The evaluation of genotype for IL-10 gene polymorphism was performed using PCR-restriction fragment length polymorphism method.

RESULTS

Statistically significant difference IL-10(-1082 G/A) gene polymorphism was determined between 2 (PTC and control) groups. No difference was determined with respect to IL-10(-592 A/C) and IL-10(-819 C/T) gene polymorphisms, and IL-10(-1082 G/A), IL-10(-592 A/C), and IL-10(-819 C/T) allele frequencies of participating between the control group and the patients with PTC (p>0.05).

CONCLUSIONS

The polymorphism of IL-10(-1082 G/A) gene was significantly associated with the occurrence of PTC. Such studies will contribute significantly to our understanding of the biological role of IL-10(-1082 G/A) gene polymorphism in PTC development. In conclusion, IL-10(-1082 G/A) gene polymorphism may affect the survival of papillary thyroid carcinoma.

摘要

目的

白细胞介素-10(IL-10)是一种主要的抗炎细胞因子,在免疫系统调节中起关键作用。据报道,慢性炎症是甲状腺肿瘤形成的一个危险因素。细胞因子和其他炎症相关基因的种系变异会改变引发炎症反应的倾向。我们假设促炎基因型与甲状腺癌呈正相关。我们旨在评估IL-10(-1082 G/A)、IL-10(-592 A/C)和IL-10(-819 C/T)多态性的基因型和等位基因频率之间的关系,以及它们与土耳其人群中发生乳头状甲状腺癌(PTC)风险的关联。

研究设计与方法

本研究纳入了42例PTC患者和113例健康对照。PTC的诊断通过手术后的组织病理学检查得以证实。使用聚合酶链反应-限制性片段长度多态性方法对IL-10基因多态性的基因型进行评估。

结果

在2组(PTC组和对照组)之间确定了IL-10(-1082 G/A)基因多态性存在统计学显著差异。在IL-10(-592 A/C)和IL-10(-819 C/T)基因多态性方面以及对照组与PTC患者之间参与的IL-10(-1082 G/A)、IL-10(-592 A/C)和IL-10(-819 C/T)等位基因频率方面均未确定差异(p>0.05)。

结论

IL-10(-1082 G/A)基因多态性与PTC的发生显著相关。此类研究将对我们理解IL-10(-1082 G/A)基因多态性在PTC发生发展中的生物学作用有显著贡献。总之,IL-10(-1082 G/A)基因多态性可能影响乳头状甲状腺癌的生存。

相似文献

1
Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.土耳其人群中甲状腺乳头状癌患者的白细胞介素-10基因多态性
J Endocrinol Invest. 2008 Sep;31(9):750-4. doi: 10.1007/BF03349252.
2
The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients.白细胞介素-6 基因中的 (-174) G/C 多态性与土耳其患者甲状腺乳头状癌的风险相关。
J Endocrinol Invest. 2009 Jun;32(6):491-4. doi: 10.1007/BF03346494. Epub 2009 Apr 15.
3
Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.土耳其人群中甲状腺乳头状癌患者的Fas/Fas配体基因多态性
J Endocrinol Invest. 2007 May;30(5):411-6. doi: 10.1007/BF03346319.
4
Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.白细胞介素-10 - 1082基因多态性与甲状腺乳头状癌相关。
Mol Biol Rep. 2014 May;41(5):3091-7. doi: 10.1007/s11033-014-3169-7. Epub 2014 Jan 28.
5
Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.白细胞介素-27基因多态性与甲状腺乳头状癌风险之间的关联。
Biomark Med. 2017 Feb;11(2):141-149. doi: 10.2217/bmm-2016-0283. Epub 2016 Dec 8.
6
Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.上游转录因子1(USF1)单核苷酸多态性与甲状腺乳头状癌易感性的关联。
Clin Endocrinol (Oxf). 2016 Apr;84(4):564-70. doi: 10.1111/cen.12832. Epub 2015 Aug 14.
7
MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.MMP-9-1562 C/T 单核苷酸多态性与甲状腺乳头癌进展过程中 MMP-9 水平和活性的增加有关。
Pathology. 2019 Jan;51(1):55-61. doi: 10.1016/j.pathol.2018.10.008. Epub 2018 Nov 27.
8
Interleukin 27 -964A > G genetic polymorphism and serum IL-27p28 levels in Chinese patients with papillary thyroid cancer.中国乳头状甲状腺癌患者白细胞介素27 -964A > G基因多态性与血清白细胞介素27 p28水平
Tumour Biol. 2015 Sep;36(10):8207-11. doi: 10.1007/s13277-015-3570-4. Epub 2015 May 21.
9
Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.血管内皮生长因子G+405C多态性可能会增加患乳头状甲状腺癌的风险。
J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22110. Epub 2016 Dec 7.
10
Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.白细胞介素-11 受体α启动子多态性-106A/G 与韩国人群甲状腺乳头状癌的相关性。
Surgery. 2012 Feb;151(2):323-9. doi: 10.1016/j.surg.2011.07.014. Epub 2011 Oct 6.

引用本文的文献

1
Impacts of Interleukin-10 Promoter Genotypes on Prostate Cancer.白细胞介素-10启动子基因型对前列腺癌的影响。
Life (Basel). 2024 Aug 20;14(8):1035. doi: 10.3390/life14081035.
2
Association of Inflammation-Related Gene Polymorphisms With Susceptibility and Radiotherapy Sensitivity in Head and Neck Squamous Cell Carcinoma Patients in Northeast China.中国东北地区头颈部鳞状细胞癌患者炎症相关基因多态性与易感性及放疗敏感性的相关性
Front Oncol. 2021 Jun 4;11:651632. doi: 10.3389/fonc.2021.651632. eCollection 2021.
3
Impact of Promoter Polymorphisms and IL-10 Serum Levels on Advanced Laryngeal Squamous Cell Carcinoma and Survival Rate.

本文引用的文献

1
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.白细胞介素-10 [ATA] 启动子单倍型与前列腺癌风险:一项基于人群的研究。
Eur J Cancer. 2007 Feb;43(3):472-5. doi: 10.1016/j.ejca.2006.11.003. Epub 2006 Dec 19.
2
Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.Toll样受体、白细胞介素-10及白细胞介素-10受体α基因多态性与淋巴瘤风险
Genes Immun. 2006 Dec;7(8):615-24. doi: 10.1038/sj.gene.6364337. Epub 2006 Sep 14.
3
Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review.
启动子多态性和血清 IL-10 水平对晚期喉鳞状细胞癌及生存率的影响。
Cancer Genomics Proteomics. 2021 Jan-Feb;18(1):53-65. doi: 10.21873/cgp.20241.
4
Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.甲状腺癌中的白细胞介素:从基础研究到临床实践的应用。
Front Immunol. 2020 Jun 12;11:1124. doi: 10.3389/fimmu.2020.01124. eCollection 2020.
5
Interleukins as markers of inflammation in malignant and benign thyroid disease.白细胞介素作为良恶性甲状腺疾病炎症的标志物。
Inflamm Res. 2014 Aug;63(8):667-74. doi: 10.1007/s00011-014-0739-z. Epub 2014 May 3.
6
Association of interleukin-10 promoter polymorphisms and corresponding plasma levels with susceptibility to laryngeal squamous cell carcinoma.白细胞介素-10启动子多态性及其相应血浆水平与喉鳞状细胞癌易感性的关联。
Oncol Lett. 2014 May;7(5):1721-1727. doi: 10.3892/ol.2014.1914. Epub 2014 Feb 26.
7
Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population.FOS-Like Antigen-2 启动子多态性与韩国人群甲状腺乳头状癌的关联研究。
Clin Exp Otorhinolaryngol. 2014 Mar;7(1):42-6. doi: 10.3342/ceo.2014.7.1.42. Epub 2014 Feb 5.
8
Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.白细胞介素-10 - 1082基因多态性与甲状腺乳头状癌相关。
Mol Biol Rep. 2014 May;41(5):3091-7. doi: 10.1007/s11033-014-3169-7. Epub 2014 Jan 28.
9
The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.白细胞介素-10 启动子多态性 rs1800872(-592C>A)与癌症易感性相关:16785 例病例和 19713 例对照的荟萃分析。
PLoS One. 2013;8(2):e57246. doi: 10.1371/journal.pone.0057246. Epub 2013 Feb 27.
10
siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.siRNA 介导的 TC21 下调使食管癌细胞对顺铂敏感。
World J Gastroenterol. 2012 Aug 21;18(31):4127-35. doi: 10.3748/wjg.v18.i31.4127.
白细胞介素基因多态性与乳腺癌:一项病例对照研究及系统文献综述
BMC Cancer. 2006 Jul 14;6:188. doi: 10.1186/1471-2407-6-188.
4
Interleukin-10 polymorphisms, cancer susceptibility and prognosis.白细胞介素-10基因多态性、癌症易感性与预后
Fam Cancer. 2006;5(2):143-9. doi: 10.1007/s10689-005-0072-3.
5
SNP-SNP interactions in breast cancer susceptibility.乳腺癌易感性中的单核苷酸多态性-单核苷酸多态性相互作用
BMC Cancer. 2006 May 3;6:114. doi: 10.1186/1471-2407-6-114.
6
Interleukin-10 promoter polymorphisms in patients with hepatitis B virus infection or hepatocellular carcinoma in Chinese Han ethnic population.中国汉族人群中乙型肝炎病毒感染患者或肝细胞癌患者白细胞介素-10启动子多态性
Hepatobiliary Pancreat Dis Int. 2006 Feb;5(1):60-4.
7
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells.甲状腺癌细胞的存活和生长需要自分泌白细胞介素-4和白细胞介素-10。
Cancer Res. 2006 Feb 1;66(3):1491-9. doi: 10.1158/0008-5472.CAN-05-2514.
8
Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan.台湾地区白细胞介素-10基因单倍型与肝细胞癌的相关性
Tissue Antigens. 2006 Feb;67(2):127-33. doi: 10.1111/j.1399-0039.2006.00536.x.
9
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.肿瘤坏死因子和白细胞介素10的基因变异与非霍奇金淋巴瘤风险:来自InterLymph联盟的报告。
Lancet Oncol. 2006 Jan;7(1):27-38. doi: 10.1016/S1470-2045(05)70434-4.
10
TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer.肺癌患者的肿瘤坏死因子-α、肿瘤坏死因子-β、白细胞介素-6和白细胞介素-10基因多态性
Dis Markers. 2005;21(3):157-65. doi: 10.1155/2005/707131.